We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Get the latest from JAMA Psychiatry
Please Wait... Processing your request... Please Wait.

Not a subscriber yet?

Subscribe to JAMA Psychiatry for 12 months of high-impact, peer-reviewed original articles and unique features. Subscribe/Learn More

JAMA Psychiatry Tweets

Follow us on Twitter

Connect with us on Google+

Current Highlights

Follow Us

Original Investigation | June 3, 2015 FREE ONLINE FIRST

Epidemiology of DSM-5 Alcohol Use Disorder

This national epidemiologic survey finds that alcohol use disorder is highly prevalent, highly comorbid, and disabling, with an urgent need for education of the public and policy makers, destigmatization of the disorder, and encouragement of those with the disorder to seek treatment.

Original Investigation | May 27, 2015 FREE ONLINE FIRST

Psychotic Experiences in the General Population of 18 Countries

This population epidemiology study uses WHO survey data to provide a comprehensive description of psychotic experiences among adults and serves as a foundation for further research about these rare variegated episodes.

Original Investigation | May 20, 2015 FREE ONLINE FIRST

Neuroticism and Polygenic Association With Major Depressive Disorder

This genome-wide association analysis identifies a novel locus for neuroticism and shows polygenic association with major depressive disorder (MDD).

Original Investigation | May 20, 2015 FREE ONLINE FIRST

Patterns of White Matter Abnormalities in First-Episode Schizophrenia

This cross-sectional diffusion tensor imaging study found 2 distinct patterns of white matter abnormalities exist at the early phase of schizophrenia, with those having global abnormalities experiencing more severe negative symptoms.

Original Investigation | May 13, 2015 ONLINE FIRST

d-Cycloserine as Adjunct to Cognitive Behavioral Therapy in OCD

This randomized clinical trial examines whether d-cycloserine augments cognitive behavioral therapy in the treatment of obsessive-compulsive disorder (OCD) and whether concomitant use of antidepressants moderates the effects of d-cycloserine.

Explore more articles:  Current Issue | Online First

Multimedia >

Author Interview

Author photo

Interview with Marsha M. Linehan, PhD, author of Dialectical Behavior Therapy for High Suicide Risk in Individuals With Borderline Personality Disorder: A Randomized Clinical Trial and Component Analysis

audio player


Dialectical Behavior Therapy for High Suicide Risk in Individuals With Borderline Personality Disorder:  A Randomized Clinical Trial and Component Analysis

All Author Interviews >

Article Video

Video thumbnail

The Tradition and Future of JAMA Psychiatry (02:22)

Stephan Heckers, MD, Editor, provides an overview of JAMA Psychiatry.

All Article Videos >


Interactive preview

All Interactive >

Author Readings
Author photo

audio player


Reader Comments

Introducing Reader Comments, a new way for readers to discuss JAMA Psychiatry articles. Select the Comments tab on article pages to read any comments and submit your own. Letters submitted to JAMA Psychiatry for consideration for print and online (archival) publication but not accepted may be accepted as Comments.

Firearm Violence

Articles from the JAMA Network

Image of JAMA forum logo

Physician Jobs